☆ 4.7 Article

CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery

CELLULAR & MOLECULAR IMMUNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Prognostic Impact of PD-1 on Tumor-Infiltrating Lymphocytes in 433 Resected Esophageal Cancers

Daichi Nomoto et al.

Summary: Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have shown antitumor effects in esophageal cancer. PD-1 expression on TILs was associated with poor clinical outcomes while the combination of PD-1 and PD-L1 expression allowed further patient classification based on outcomes.

ANNALS OF THORACIC SURGERY (2022)

添加到收藏夹

Editorial Material Immunology

CD226: a potent driver of antitumor immunity that needs to be maintained

Jiacheng Bi

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

添加到收藏夹

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Article Immunology

Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses

Karl L. Banta et al.

Summary: Dual blockade of PD-1 and TIGIT is effective in enhancing anti-tumor CD8(+) T cell responses, with concurrent blockade of CD28 and CD226 being necessary for optimal therapeutic effect.

IMMUNITY (2022)

添加到收藏夹

Review Oncology

TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy

Eugene Y. Chiang et al.

Summary: Recent advances in understanding immune checkpoints have led to successful therapeutic strategies that have fundamentally changed oncology practice. Currently, only two immune therapies targeting CTLA-4 and PD-L1/PD-1 have been approved. TIGIT, a member of the PVR/nectin family, acts as a checkpoint inhibitor and regulates the activity of the costimulatory receptor CD226. Several TIGIT-directed blocking antibodies are currently being developed for clinical use.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Article Biology

Delineating the transcriptional landscape and clonal diversity of virus-specific CD4+ T cells during chronic viral infection

Ryan Zander et al.

Summary: Recent evidence reveals the complex developmental relationships between different subsets of CD4(+) T cells responding to chronic viral infection. Single-cell RNA sequencing and T cell receptor sequencing were performed on virus-specific CD4(+) T cells isolated from mice infected with chronic lymphocytic choriomeningitis virus (LCMV) infection. The study identifies unique transcriptional states among various CD4(+) T cell subsets and suggests the potential impact of T cell receptor usage on CD4(+) T cell development during chronic infection.

ELIFE (2022)

添加到收藏夹

Article Medicine, General & Internal

Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy

Zicheng Zhang et al.

Summary: This study conducted a comprehensive analysis of T cell exhaustion (TEX) within the tumor microenvironment (TME). The researchers identified five pan-cancer TEX subsets and revealed tissue-specific patterns and prognostic implications. They also discovered previously unknown TEX-associated cancer genes and developed a machine learning-based gene signature to model the hierarchical stages of TEX.

EBIOMEDICINE (2022)

添加到收藏夹

Article Oncology

Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer

Celine M. Laumont et al.

Summary: The coexpression of CD39, CD103, and PD-1 in high-grade serous ovarian cancer delineated highly activated CD8(+) and CD4(+) TIL, demonstrating cytolytic, humoral, and regulatory immune functions, with significant prognostic impact. Triple-positive TIL represent promising targets for combination immunotherapy strategies.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Integrated analysis of multimodal single-cell data

Yuhan Hao et al.

Summary: The study introduces a weighted-nearest neighbor analysis framework to learn the relative utility of each data type in each cell, enabling integrative analysis of multiple modalities. Applied to a CITE-seq dataset, the method constructs a multimodal reference atlas of the circulating immune system and successfully identifies and validates previously unreported lymphoid subpopulations.

CELL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival

Sara Valpione et al.

Summary: High baseline T cell receptor diversity is predictive of favorable prognosis in multiple cancer types, while monoclonal expansion of T cells pre-treatment correlates with good response to immune checkpoint blockade therapy in metastatic melanoma patients.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Cell Biology

A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy

Li-Heng Che et al.

Summary: Our study utilized single-cell transcriptome analysis to reveal that the TME of treatment-naive tumors is characterized by the higher abundance of less-activated B cells and higher heterogeneity of TAMs. In contrast, tumors treated with PC showed activation of B cells, lower diversity of TAMs with immature and less activated phenotype, lower abundance of dysfunctional T cells and ECM-remodeling cancer-associated fibroblasts, and an accumulation of myofibroblasts. This provides a foundation for future research on cellular mechanisms underlying liver metastasis of CRC and its response to PC.

CELL DISCOVERY (2021)

添加到收藏夹

Review Oncology

Strategies to tackle RAS-mutated metastatic colorectal cancer

G. Patelli et al.

Summary: RAS oncogene is commonly mutated in cancer, particularly in metastatic colorectal cancer (mCRC), leading to poor prognosis and resistance to certain treatments. Recent advancements in specific KRAS(G12C) inhibitors have renewed interest in targeting this biomarker. Direct KRAS(G12C) inhibition is emerging as a promising strategy in mCRC and other solid malignancies, showing potential for improved treatment efficacy in the future.

ESMO OPEN (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer

Mei Feng et al.

Summary: The study shows that inhibition of BCL9 can reduce tumor growth, promote CD8(+) T cell infiltration into tumors, and enhance response to anti-PD-1 treatment. The mechanism of BCL9 involves regulation of CD155-CD226 and CD155-CD96 checkpoints.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Article Pathology

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma

Laura Martin de la Fuente et al.

VIRCHOWS ARCHIV (2020)

添加到收藏夹

Article Oncology

CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy

Hyung-seung Jin et al.

CANCER IMMUNOLOGY RESEARCH (2020)

添加到收藏夹

Article Immunology

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8(+) T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

Marianne Weulersse et al.

IMMUNITY (2020)

添加到收藏夹

Article Immunology

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

Matthias Braun et al.

IMMUNITY (2020)

添加到收藏夹

Article Biochemical Research Methods

Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology

Gregor Sturm et al.

BIOINFORMATICS (2019)

添加到收藏夹

Review Oncology

DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy

Beatriz Sanchez-Correa et al.

CANCERS (2019)

添加到收藏夹

Article Medicine, Research & Experimental

CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration

Hana Triki et al.

LIFE SCIENCES (2019)

添加到收藏夹

Article Biochemical Research Methods

Fast, sensitive and accurate integration of single-cell data with Harmony

Ilya Korsunsky et al.

NATURE METHODS (2019)

添加到收藏夹

Review Immunology

Targeting PVR (CD155) and its receptors in anti-tumor therapy

Paola Kucan Brlic et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

添加到收藏夹

Article Immunology

Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection

William H. Hudson et al.

IMMUNITY (2019)

添加到收藏夹

Article Immunology

CD8+ T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients

Mengjie Wang et al.

CLINICAL IMMUNOLOGY (2018)

添加到收藏夹

Review Immunology

Immune Responses in the Liver

Paul Kubes et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)

添加到收藏夹

Article Oncology

Surgical Treatment of Metastatic Colorectal Cancer

Jeffery Chakedis et al.

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)

添加到收藏夹

Article Oncology

NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome

Concepcion F. Guillamon et al.

CANCER IMMUNOLOGY RESEARCH (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Evolution of Metastases in Space and Time under Immune Selection

Mihaela Angelova et al.

CELL (2018)

添加到收藏夹

Article Immunology

Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8(+) T cell dysfunction and maintain memory phenotype

Bei Wang et al.

SCIENCE IMMUNOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer

Claudio Isella et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article

The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease

Gero Brockhoff et al.

Oncotarget (2017)

添加到收藏夹

Article Oncology

PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer

Dagmar Kollmann et al.

ONCOIMMUNOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

QuPath: Open source software for digital pathology image analysis

Peter Bankhead et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

Antonio Colaprico et al.

NUCLEIC ACIDS RESEARCH (2016)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

Etienne Becht et al.

GENOME BIOLOGY (2016)

添加到收藏夹

Article Medicine, Research & Experimental

TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients

Joe-Marc Chauvin et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

添加到收藏夹

Article Immunology

Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis

Masahiro Ayano et al.

JOURNAL OF IMMUNOLOGY (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes

Jehan El-Jawhari et al.

MOLECULAR IMMUNOLOGY (2014)

添加到收藏夹

Article Oncology

Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy

Niels Halama et al.

CANCER RESEARCH (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer

Jonathan A. D. Simpson et al.

GUT (2010)

添加到收藏夹

Article Oncology

T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases

Steven C. Katz et al.

ANNALS OF SURGICAL ONCOLOGY (2009)

添加到收藏夹

Article Immunology

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

Susan Gilfillan et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

添加到收藏夹

Article Multidisciplinary Sciences

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Jerom Galon et al.

SCIENCE (2006)

添加到收藏夹

Article Oncology

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

ME Dudley et al.

JOURNAL OF IMMUNOTHERAPY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.